ME Medication-Assisted Treatment (MAT) Guide for 2024
Key Takeaways
- Maine's MAT framework covers buprenorphine, methadone, and naltrexone alongside counseling, with MaineCare reimbursing medication, prescriber visits, and behavioral health services under its benefit 4.
- Geography shapes the choice: Portland concentrates OTPs and office-based prescribers, while rural Mainers often rely on telehealth and primary care buprenorphine since the X-waiver was removed 3, 5.
- Medication cadence determines weekly life—daily home dosing with Suboxone, daily OTP visits for methadone, or a monthly Vivitrol injection after detox—each paired with outpatient counseling.
- A practical next step is calling a Maine program and asking about medication options, counseling integration, relapse protocols, telehealth, and how MaineCare or commercial insurance applies.
Starting Medication-Assisted Treatment (MAT) in Maine
You're likely here because you're considering medication-assisted treatment (MAT) for yourself or a loved one. This guide will walk you through what to expect when starting MAT in Maine, from the initial steps to understanding the different treatment options and how they integrate into your life.
Starting MAT typically involves a phone call, an intake appointment, and a conversation with a clinician. They will ask about your substance use history, current challenges, and daily routine to determine the best course of action. This might include deciding whether to pick up a prescription at a pharmacy, attend an opioid treatment program, or receive a monthly injection. The process also involves engaging with counseling and behavioral therapies, which are integral to MAT, fitting into your schedule alongside work, family, or other commitments.
Maine's Office of Behavioral Health emphasizes that MAT involves medications like methadone and Suboxone used in conjunction with counseling and behavioral therapies 4. The medication helps stabilize your body, reducing cravings and withdrawal symptoms, which creates a foundation for therapy, improving sleep, repairing relationships, and developing new coping mechanisms 2.
The initial step can feel daunting, but it's often the most significant hurdle. This guide aims to clarify what comes next, helping you navigate the process with confidence.
MAT Explained: A Medical Foundation for Recovery
It's important to understand that MAT is not simply replacing one substance with another. It is a medical treatment for a medical condition, similar to how insulin manages diabetes or an inhaler treats asthma. The medications used—buprenorphine, methadone, and naltrexone—work to alleviate cravings and the intense physical pull of opioids. This stabilization allows your brain to focus on the therapeutic work necessary for recovery.
Consider MAT as providing a stable foundation. When your body is not in constant distress from withdrawal or cravings, you can engage more effectively in counseling sessions, attend group therapy without the burden of physical discomfort, and manage daily responsibilities. The Substance Abuse and Mental Health Services Administration (SAMHSA) highlights that research consistently shows that combining medication with therapy effectively treats substance use disorders and helps sustain recovery for many individuals 2.
Evidence supports this approach: in outpatient settings, MAT combined with counseling significantly improves treatment retention and reduces opioid use compared to non-medication-assisted approaches 10. The medication is not a shortcut; it makes the sustained effort of recovery possible.
Understanding MAT Medications and Their Impact on Lifestyle
Buprenorphine (Suboxone): Flexible, Office-Based Care
For many individuals starting MAT in Maine, buprenorphine, often known by its brand name Suboxone, is the primary option discussed. This medication is prescribed by clinicians in standard medical offices and filled at a local pharmacy. It is typically taken at home, once daily, dissolved under the tongue.
The convenience of buprenorphine is a significant advantage. It eliminates the need for daily clinic visits, allowing you to integrate treatment seamlessly into your daily life. You can take your dose privately at home, attend to family responsibilities, and go to work without your medical care being a public matter.
Recent federal changes, including the removal of the X-waiver requirement, have expanded the number of Maine providers who can prescribe buprenorphine 3. This has increased access, particularly in areas where specialty addiction providers might be scarce. National data indicates a rise in buprenorphine use and a decline in methadone use in both rural and urban populations 8, reflecting its growing accessibility and preference.
Methadone: Structured, Daily Clinic Visits
Methadone is the longest-standing medication used in MAT and requires a more structured approach. Initially, you will not receive a take-home prescription. Instead, you must visit a federally certified opioid treatment program (OTP) daily, usually in the mornings, to receive your dose. Over time, with consistent progress, you may earn take-home doses, but the initial phase demands strict adherence to daily clinic visits.
For some, this daily structure provides essential support and routine. The consistent check-ins and familiar environment can be a stabilizing factor. Maine's Office of Behavioral Health recognizes methadone, alongside Suboxone, as a core MAT medication, always combined with counseling and behavioral therapy 4.
A key challenge with methadone is geographical access. OTPs are primarily located in Maine's more populated areas. This can mean significant travel time for individuals living in rural regions, especially during the initial phase of treatment. Despite this, for those with severe opioid use disorder or who haven't found stability with buprenorphine, methadone often proves to be the most effective option.
Naltrexone (Vivitrol): Monthly Injection, Opioid-Free
Naltrexone operates differently from buprenorphine and methadone as it is not an opioid. The extended-release injectable form, commonly known as Vivitrol, works by blocking opioid receptors. This means that if opioids are used, their effects will not be felt. The medication is administered as a single injection once a month by a clinician, simplifying the daily routine.
An important consideration for naltrexone is the requirement to be completely opioid-free, typically for about a week, before the first injection. This detox period is crucial and often means naltrexone is initiated after a medical detox, a residential treatment stay, or a period of abstinence, rather than at the very beginning of treatment.
Naltrexone is well-suited for individuals who have completed withdrawal and prefer a monthly appointment over a daily medication regimen, making it compatible with a busy work schedule. It is also effective in treating alcohol use disorder, offering a dual benefit if alcohol is also a concern. SAMHSA includes naltrexone as a core medication, to be combined with counseling, for opioid use disorder 2.
Comparing MAT Options: How Each Fits Your Week
The choice of MAT medication significantly impacts your weekly schedule. Buprenorphine is often the first recommendation in Maine, offering the flexibility of home dosing, pharmacy pickup, and office-based prescribing without requiring a specialized opioid treatment program 4. National data confirms the increasing preference for buprenorphine over methadone in both urban and rural areas 8. Methadone provides a highly structured environment with daily clinic visits during the initial months, which offers stability but requires a time commitment for travel. Naltrexone, administered as a monthly injection after detox, offers an opioid-free option with minimal daily impact.
Regardless of the medication chosen, all three are integrated with counseling and behavioral therapy. This combination is fundamental to the MAT model 2, 4. Your medication choice ultimately shapes how your treatment fits into your daily life.
| Medication | Dosing Cadence | Access in Maine | Counseling Integration |
|---|---|---|---|
| Buprenorphine (Suboxone) | Daily, at home | Office-based prescriber, pharmacy pickup | Paired with outpatient counseling |
| Methadone | Daily, in person (early phase) | Certified opioid treatment program (OTP) | Counseling on-site at OTP |
| Naltrexone (Vivitrol) | Monthly injection | Clinician's office, post-detox | Paired with outpatient counseling |
Recovery Starts With a Conversation
Whether you’re exploring recovery for yourself or seeking guidance for someone you care about, Coastal Recovery Partners is here to help. Our team offers trauma-informed, evidence-based support grounded in structure, compassion, and real connection—without pressure or judgment.
When you’re ready, we’ll meet you where you are and help you take the next step forward.
Your First 90 Days: A Week-by-Week Overview
The initial three months of MAT are a dynamic period, characterized by significant adjustments and progress. Understanding this trajectory can help manage expectations and reduce disorientation during the early stages.
Week 1: Intake and Induction. This begins with a comprehensive assessment by a clinician, covering your medical history, substance use patterns, mental health, and any prior treatments. You'll discuss which medication best suits your situation. If buprenorphine is chosen, induction typically occurs when you are in mild withdrawal, with close monitoring for the first few days to adjust the dosage. This period can be physically and emotionally taxing. Counseling appointments will be scheduled, even if your first full session is yet to come 2.
Weeks 2–4: Stabilization and Engagement. During this phase, the medication begins to stabilize your system. Cravings diminish, and sleep patterns may become more regular. You'll start meeting with your individual counselor and attending initial group therapy sessions. Many find this period surprisingly ordinary, though old habits and triggers may still be present. The medication's role is to provide a steady baseline, allowing you to consistently attend appointments and openly communicate with your clinician about your experiences.
Months 2–3: Skill-Building and Relapse Prevention. The focus shifts from immediate stabilization to developing long-term coping strategies. You'll learn to identify triggers, practice managing cravings, and rebuild healthy routines for sleep, nutrition, and daily structure. The evidence for outpatient MAT underscores the importance of this combined approach: medication alongside psychosocial support significantly improves treatment retention and reduces opioid use compared to medication-only or therapy-only approaches 10. This integrated model is what provides lasting support 2.
After 90 days, you won't necessarily be "finished" with treatment, but you will likely feel more stable. You'll have a clearer understanding of your routine, a supportive relationship with your counselor, and a medication regimen tailored to your needs. This foundational stability is the primary goal of the first three months.
Integrating MAT within Outpatient Care: OP, IOP, and PHP
MAT is a medication plan that complements a specific level of care, not a level of care itself. The appropriate level of care determines the intensity and frequency of your therapy and group sessions, based on your current needs and stability.
Standard outpatient (OP) care offers the least intensive support, typically involving one or two appointments per week, such as a counseling session and a check-in with your prescriber. This level is suitable for individuals who have achieved a degree of stability or whose substance use is identified early with minimal disruption to their lives. MAT integrates smoothly here: you take your buprenorphine at home, attend counseling, and manage the rest of your week independently.
Intensive outpatient (IOP) is a moderate level of care, often where many working adults in Maine find effective support. Maine's Office of Behavioral Health describes IOP as structured therapy several days a week, with MAT—whether methadone or Suboxone—integrated with counseling and behavioral therapy 4. You might attend group sessions three or four mornings or evenings weekly, learning relapse prevention skills while medication manages cravings. Research indicates that well-structured IOPs can be as effective as inpatient treatment for many individuals 12, making it a viable option for those who cannot take extended time away from work or family.
Partial hospitalization (PHP) represents the most intensive outpatient option, often requiring attendance five days a week for several hours daily. This level of care is typically recommended after detox or residential treatment, or when IOP proves insufficient. MAT continues uninterrupted through PHP, with the focus shifting to intensive therapeutic engagement. The progression from PHP to IOP to OP is a strategic step-down process, indicating increasing self-management as the medication and therapeutic skills become more effective.
The Role of Counseling and Trauma-Aware Care in MAT
Trauma-informed care is a critical component of effective MAT, moving beyond a mere buzzword to a practical approach that profoundly impacts treatment engagement. When genuinely implemented, it transforms the intake process and ongoing therapy.
During intake, a trauma-informed approach means you won't be pressured to recount traumatic experiences immediately. Clinicians will explain the purpose of each question, offer options to skip questions, and allow you to control the pace of the discussion. In group settings, clear boundaries are established: no graphic details that could overwhelm others, no pressure to share before you're ready, and a discreet way to step out if needed. Crucially, if a relapse occurs—which is a recognized part of the recovery process for some—the response is clinical adjustment rather than punishment. This involves reviewing your medication dose, exploring contributing factors with your counselor, and adjusting support, rather than expulsion from the program.
The evidence is clear: trauma-informed approaches enhance treatment engagement and reduce distress for individuals with co-occurring trauma and substance use disorders 11. Given that many individuals entering MAT have a history of trauma underlying their substance use, an intake process that acknowledges and addresses this is vital for retaining individuals in treatment.
Addressing the Treatment Gap: Why Engagement Matters
A significant challenge in substance use treatment is the "treatment gap." Nationally, in 2024, only about 19.3% of individuals aged 12 or older who needed substance use treatment in the past year actually received it 9. This means four out of five people did not access care, not because treatment is ineffective, but because they never initiated it.
This gap is fueled by various factors: stigma, concerns about cost, lack of information on where to seek help, fear of judgment from family or employers, and a reasonable apprehension that the healthcare system may not treat them with dignity. If you've been among the majority who haven't accessed treatment, it reflects a systemic issue, not a personal failing.
Your decision to engage is the most critical variable you control. The program is structured to support you with everything else.
Accessing MAT in South Portland and Rural Maine
Portland as a Hub, Telehealth for Inland Access
The South Portland and greater Portland area serves as a central hub for MAT services in Maine. This region concentrates office-based buprenorphine prescribers, opioid treatment programs for methadone, and outpatient programs offering IOP and PHP. If you reside in this area, finding an initial appointment within a reasonable travel distance is generally feasible.
However, access becomes more challenging for those living further inland. The Health Resources and Services Administration (HRSA) identifies common barriers in rural areas, including long travel distances to providers, a limited clinician workforce, community stigma, and transportation difficulties, especially during winter 5. The federal removal of the X-waiver has been instrumental in allowing more clinicians, including primary care providers, to prescribe buprenorphine 3, significantly improving access in areas previously lacking specialty addiction services.
Telehealth has emerged as a vital solution, bridging geographical gaps. Regular video visits with prescribers, combined with local or remote counseling, enable many rural Mainers to maintain MAT without extensive travel. Maine's healthcare system often employs a "hub-and-spoke" model, similar to Vermont's, where specialized programs in urban centers act as hubs, and local providers or telehealth clinicians serve as spokes, providing ongoing care 7.
MaineCare Coverage and Cost Inquiries
Concerns about cost should not be a barrier to seeking treatment. MaineCare, the state's Medicaid program, provides comprehensive coverage for substance use disorder treatment services, including MAT and intensive outpatient care, under its behavioral health benefits 4. This means that medication, prescriber visits, and associated counseling are typically covered if you have MaineCare.
For those with commercial insurance through employment or the marketplace, MAT is generally covered, but specific details can vary. It's crucial to inquire about copays for counseling, prior authorization requirements for medications, and whether specific prescribers are in-network. Before enrolling in any program, ask direct questions: "Do you accept my insurance?" "What will my out-of-pocket costs be per visit?" "Do you manage prior authorizations for buprenorphine or Vivitrol?" "Is a sliding scale available if my coverage changes?" A program that provides clear answers to these questions demonstrates a commitment to facilitating access beyond just clinical care.
Key Questions to Ask Any Maine MAT Program
Before committing to a MAT program, it's important to ask informed questions. This initial inquiry can provide valuable insight into whether a program is the right fit for your needs. A brief phone call can reveal a lot about a program's approach and support systems.
Consider asking the following questions:
- Which medications do you offer, and how is the choice determined? A comprehensive program should discuss buprenorphine, methadone, or naltrexone and explain how the decision is made collaboratively with you, not for you 2.
- How is counseling integrated with medication? MAT is defined by the combination of medication with counseling and behavioral therapy 4. Inquire about how this integration will fit into your schedule.
- What levels of care are available, and how do transitions work? Look for a program that can facilitate movement between PHP, IOP, and standard outpatient care without requiring you to restart your treatment journey 12.
- What is the protocol if I experience a relapse? The response should be clinical and supportive—focusing on dose review and increased support—rather than punitive 11.
- Do you accept my insurance, and what are the expected costs? Ask about MaineCare, commercial plans, and the process for prior authorizations.
- If I live in a rural area, can parts of my treatment be conducted via telehealth? Telehealth is often crucial for maintaining access in rural Maine 5.
If a program's answers are vague or unhelpful, it's a sign to explore other options. You have the right to find a program that meets your needs and provides clear, supportive information.
Taking the Next Step in Your Recovery Journey
Acknowledging the need for help and seeking information is a significant first step. The next action can be intentionally small: choose a program in or near South Portland and make a phone call. Use the questions outlined above to guide your conversation, focusing on medication options, counseling integration, relapse protocols, and insurance coverage.
Listen for clear, empathetic responses from staff who are experienced in guiding individuals through this process. You don't need to have all the answers—you don't need to know which medication is best, have your entire week planned out, or be completely confident in your ability to succeed. The intake process is designed for individuals who are uncertain, tired, but willing to make that initial call.
An integrated outpatient program that combines MAT with counseling, trauma-aware care, and a flexible schedule is essential for long-term success 2, 10. Coastal Recovery Partners in South Portland offers this type of comprehensive care. The most important action is to make that call, wherever you choose to seek help.
Frequently Asked Questions
Is MAT just replacing one drug with another?
No, MAT is a medical treatment for a medical condition. Medications like buprenorphine, methadone, and naltrexone are FDA-approved to reduce cravings and withdrawal symptoms, creating stability for therapy and skill-building. SAMHSA states that combining medication and therapy effectively treats substance use disorders and helps sustain recovery 2.
Does MaineCare cover medication-assisted treatment?
Yes, MaineCare covers substance use disorder treatment services, including MAT and intensive outpatient care, as part of its behavioral health benefit 4. This includes medication, prescriber visits, and counseling. Most commercial insurance plans also cover MAT, but it's advisable to confirm specific copays and prior authorization requirements with the program directly.
Can I continue working and parenting while on MAT?
Yes, most individuals on MAT maintain their work and family responsibilities. Buprenorphine is typically taken at home daily. Intensive outpatient programs are often scheduled to accommodate working adults, with group sessions several mornings or evenings a week. Research shows that well-structured IOPs can be as effective as inpatient treatment for many individuals 12, allowing you to receive care without disrupting your life.
How can I access MAT if I live in rural Maine, far from Portland?
Telehealth has significantly improved access. The federal removal of the X-waiver has allowed more clinicians, including primary care providers, to prescribe buprenorphine 3. While rural areas face barriers like travel distance and provider shortages, telehealth and integrated care models help bridge this gap 5. Often, a video visit with a prescriber combined with local counseling can be an effective solution.
How long is MAT typically needed?
There is no set duration for MAT; it varies for each individual. Some may be on MAT for a year, others for several years, and some for longer. Outpatient evidence suggests that longer retention on medication is associated with better treatment outcomes and reduced opioid use 10. The decision on treatment length is made collaboratively with your clinician based on your progress and needs, not an arbitrary timeline.
What happens if I relapse while on MAT?
A supportive program views relapse as a clinical event, not a reason for expulsion. If a relapse occurs, the response should be a clinical adjustment: your dose may be reviewed, your counselor will explore the circumstances leading to the relapse, and your support plan will be adjusted. Trauma-informed approaches are crucial here, as they improve engagement and reduce distress for individuals managing relapse and co-occurring trauma 11. Open communication with your clinician is key to navigating these situations.
References
- 2023 NSDUH: Maine – Selected Drug Use and Mental Health Estimates. https://www.samhsa.gov/data/sites/default/files/reports/rpt56188/2023-nsduh-sae-state-tables_0/2023-nsduh-sae-state-tabs-maine.pdf
- Treatment Options for Substance Use Disorder. https://www.samhsa.gov/substance-use/treatment/options
- Substance Use Disorders: Statutes, Regulations, and Guidelines. https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines
- Substance Use Disorder Treatment Services – Maine Office of Behavioral Health. https://www.maine.gov/dhhs/obh/support-services/substance-use-disorder-services/treatment-services
- Enhancing Rural Access to Medications for Opioid Use Disorder. https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/rural/moud-policy-brief-nacrhhs.pdf
- Barriers and Facilitators Associated with Establishment of Hospital-Based MOUD Programs. https://pmc.ncbi.nlm.nih.gov/articles/PMC10862358/
- Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC5537005/
- Geographic Differences in Buprenorphine and Methadone Utilization for Medications for Opioid Use Disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC12741413/
- SAMHSA Releases Annual National Survey on Drug Use and Health. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health
- Effectiveness of Medication-Assisted Treatment for Opioid Use Disorder in Outpatient Settings. https://pmc.ncbi.nlm.nih.gov/articles/PMC6698463/
- Trauma-Informed Care in Substance Use Treatment: A Systematic Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC10022925/
- Intensive Outpatient Programs for Substance Use Disorders: A Review of Evidence. https://pmc.ncbi.nlm.nih.gov/articles/PMC5741114/
